Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sucontral D
- Development stage
- Unknown
- Lead developer
- Harras Pharma Curarina
- Modality
- Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Sucontral D is a dietary supplement developed by Harras Pharma Curarina for the management of mild to moderate type 2 diabetes mellitus. The primary active component is a dry concentrate of the bark of *Hintonia latiflora*, a plant native to Central and South America, which is standardized for its polyphenol content, particularly neoflavonoids like coutareagenin. These compounds are believed to exert hypoglycemic effects by inhibiting alpha-glucosidase and potentially enhancing insulin sensitivity. The formulation is a combination product that also includes essential vitamins (C, E, B1, B2, B6, B12, folic acid, and biotin) and minerals (zinc and chromium) to support glucose metabolism and overall health in diabetic patients. It is typically administered as an oral capsule twice daily in conjunction with a prescribed diet.
- Brand names
- Sucontral D
- Other names
- Hintonia latiflora extract
02
Targets
Sucrase-Isomaltase
Beyond the preview
Go deeper on Sucontral D.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sucontral D.